Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 17;146(15):10899-10907.
doi: 10.1021/jacs.4c01667. Epub 2024 Apr 3.

γ-Amino Alcohols via Energy Transfer Enabled Brook Rearrangement

Affiliations

γ-Amino Alcohols via Energy Transfer Enabled Brook Rearrangement

Ranjini Laskar et al. J Am Chem Soc. .

Abstract

In the long-standing quest to synthesize fundamental building blocks with key functional group motifs, photochemistry in the recent past has comprehensively established its attractiveness. Amino alcohols are not only functionally diverse but are ubiquitous in the biologically active realm of compounds. We developed bench-stable bifunctional reagents that could then access the sparsely reported γ-amino alcohols directly from feedstock alkenes through energy transfer (EnT) photocatalysis. A designed 1,3-linkage across alkenes is made possible by the intervention of a radical Brook rearrangement that takes place downstream to the EnT-mediated homolysis of our reagent(s). A combination of experimental mechanistic investigations and detailed computational studies (DFT) indicates a radical chain propagated reaction pathway.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
(A) γ-Amino alcohols highlighting dual chemical functionality and their prevalence in bioactive compounds, (B) conventional methods to synthesize 1,3-amino alcohols, (C) σ-bond homolysis coupled with concurrent radical rearrangement, (D) radical Brook rearrangement, and (E) working hypothesis (this work).
Figure 2
Figure 2
(A) Reagent synthetic pathway and (B) reagent library; triplet energies (kcal·mol–1) are calculated using uB3LYP-D3/def2-svp-CPCM (DCM) level of theory. DMF = N,N-dimethylformamide.
Figure 3
Figure 3
Scope table and sensitivity screen. Standard conditions: 0.2 mmol of 1, 0.3 mmol of 2, Ir−F (1.0 mol %), and CH2Cl2 (0.05 M). Crude 1H NMR yields are given in parentheses unless otherwise mentioned. aYield after isolation of deprotected salts (0.2 mmol)—deprotection with 2.5 mL of MeOH and 2.5 mL of 1.0 M HCl solution under air for 1 h. b1H NMR yields are reported.
Figure 4
Figure 4
Product diversifications. aCrude 1H NMR yield was determined using CH2Br2 as an internal standard. CDI = 1,1′-Carbonyldiimidazole; DIPEA = N,N-Diisopropylethylamine.
Figure 5
Figure 5
Mechanistic investigations. (A) Cyclic voltammetry studies, (B) UV/vis spectroscopy, (C) direct excitation experiments, (D) employment of thermal radical initiators as control (AIBN: Azobis(isobutyronitrile), BPO: Benzoyl peroxide, DTBP: di-tert-butyl peroxide), (E) Stern–Volmer quenching analysis, (F) TEMPO-trapping experiments, and (G) quantum yield analysis.
Figure 6
Figure 6
Proposed mechanism was supported by computational studies. Calculated free Gibbs energies [CPCM(DCM) uB3LYP-D3/def2-svp] are given in kcal·mol–1. For details, see the Supporting Information.

References

    1. Ager D. J.; Prakash I.; Schaad D. R. 1,2-Amino Alcohols and Their Heterocyclic Derivatives as Chiral Auxiliaries in Asymmetric Synthesis. Chem. Rev. 1996, 96, 835–876. 10.1021/cr9500038. - DOI - PubMed
    1. Titova Y. Transition Metal Complexes with Amino Acids, Peptides and Carbohydrates in Catalytic Asymmetric Synthesis: A Short Review. Processes 2024, 12, 214.10.3390/pr12010214. - DOI
    1. Berne D.; Coste G.; Morales-Cerrada R.; Boursier M.; Pinaud J.; Ladmiral V.; Caillol S. Taking advantage of β-hydroxy amine enhanced reactivity and functionality for the synthesis of dual covalent adaptable networks. Polym. Chem. 2022, 13, 3806–3814. 10.1039/D2PY00274D. - DOI
    1. Yin Z.; Hu W.; Zhang W.; Konno H.; Moriwaki H.; Izawa K.; Han J.; Soloshonok V. A. Tailor-made amino acid-derived pharmaceuticals approved by the FDA in 2019. Amino Acids 2020, 52, 1227–1261. 10.1007/s00726-020-02887-4. - DOI - PubMed
    1. Liu A.; Han J.; Nakano A.; Konno H.; Moriwaki H.; Abe H.; Izawa K.; Soloshonok V. A. New pharmaceuticals approved by FDA in 2020: Small-molecule drugs derived from amino acids and related compounds. Chirality 2022, 34, 86–103. 10.1002/chir.23376. - DOI - PubMed